vs
Progyny, Inc.（PGNY）与VIEMED HEALTHCARE, INC.（VMD）财务数据对比。点击上方公司名可切换其他公司
Progyny, Inc.的季度营收约是VIEMED HEALTHCARE, INC.的4.2倍（$318.4M vs $76.2M）。VIEMED HEALTHCARE, INC.净利率更高（7.4% vs 3.9%，领先3.5%）。VIEMED HEALTHCARE, INC.同比增速更快（25.5% vs 6.7%）。Progyny, Inc.自由现金流更多（$48.6M vs $9.7M）。过去两年VIEMED HEALTHCARE, INC.的营收复合增速更高（22.7% vs 7.0%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
Viemed Healthcare是一家专注于呼吸护理解决方案的医疗科技企业，研发、生产及销售便携式呼吸机、呼吸治疗设备及配套支持服务，覆盖北美、欧洲及亚太核心市场的急症、亚急症及居家护理场景，服务急慢性呼吸系统疾病患者。
PGNY vs VMD — 直观对比
营收规模更大
PGNY
是对方的4.2倍
$76.2M
营收增速更快
VMD
高出18.8%
6.7%
净利率更高
VMD
高出3.5%
3.9%
自由现金流更多
PGNY
多$38.9M
$9.7M
两年增速更快
VMD
近两年复合增速
7.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $76.2M |
| 净利润 | $12.5M | $5.6M |
| 毛利率 | 24.1% | 57.9% |
| 营业利润率 | 4.8% | 11.0% |
| 净利率 | 3.9% | 7.4% |
| 营收同比 | 6.7% | 25.5% |
| 净利润同比 | 18.5% | 30.7% |
| 每股收益（稀释后） | $0.14 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYVMD
| Q4 25 | $318.4M | $76.2M | ||
| Q3 25 | $313.3M | $71.9M | ||
| Q2 25 | $332.9M | $63.1M | ||
| Q1 25 | $324.0M | $59.1M | ||
| Q4 24 | $298.4M | $60.7M | ||
| Q3 24 | $286.6M | $58.0M | ||
| Q2 24 | $304.1M | $55.0M | ||
| Q1 24 | $278.1M | $50.6M |
净利润PGNYVMD
| Q4 25 | $12.5M | $5.6M | ||
| Q3 25 | $13.9M | $3.5M | ||
| Q2 25 | $17.1M | $3.2M | ||
| Q1 25 | $15.1M | $2.6M | ||
| Q4 24 | $10.5M | $4.3M | ||
| Q3 24 | $10.4M | $3.9M | ||
| Q2 24 | $16.5M | $1.5M | ||
| Q1 24 | $16.9M | $1.6M |
毛利率PGNYVMD
| Q4 25 | 24.1% | 57.9% | ||
| Q3 25 | 23.2% | 57.5% | ||
| Q2 25 | 23.7% | 58.3% | ||
| Q1 25 | 23.4% | 56.3% | ||
| Q4 24 | 21.3% | 59.5% | ||
| Q3 24 | 20.7% | 59.3% | ||
| Q2 24 | 22.5% | 59.8% | ||
| Q1 24 | 22.4% | 58.9% |
营业利润率PGNYVMD
| Q4 25 | 4.8% | 11.0% | ||
| Q3 25 | 6.9% | 7.8% | ||
| Q2 25 | 7.3% | 8.1% | ||
| Q1 25 | 7.5% | 6.5% | ||
| Q4 24 | 5.3% | 10.6% | ||
| Q3 24 | 4.3% | 9.7% | ||
| Q2 24 | 6.8% | 6.6% | ||
| Q1 24 | 6.7% | 4.4% |
净利率PGNYVMD
| Q4 25 | 3.9% | 7.4% | ||
| Q3 25 | 4.4% | 4.9% | ||
| Q2 25 | 5.1% | 5.0% | ||
| Q1 25 | 4.6% | 4.4% | ||
| Q4 24 | 3.5% | 7.1% | ||
| Q3 24 | 3.6% | 6.7% | ||
| Q2 24 | 5.4% | 2.7% | ||
| Q1 24 | 6.1% | 3.2% |
每股收益（稀释后）PGNYVMD
| Q4 25 | $0.14 | $0.14 | ||
| Q3 25 | $0.15 | $0.09 | ||
| Q2 25 | $0.19 | $0.08 | ||
| Q1 25 | $0.17 | $0.06 | ||
| Q4 24 | $0.12 | $0.10 | ||
| Q3 24 | $0.11 | $0.10 | ||
| Q2 24 | $0.17 | $0.04 | ||
| Q1 24 | $0.17 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $13.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $516.0M | $141.5M |
| 总资产 | $742.4M | $199.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PGNYVMD
| Q4 25 | $112.2M | $13.5M | ||
| Q3 25 | $134.0M | $11.1M | ||
| Q2 25 | $132.5M | $20.0M | ||
| Q1 25 | $109.2M | $10.2M | ||
| Q4 24 | $162.3M | $17.5M | ||
| Q3 24 | $91.5M | $11.3M | ||
| Q2 24 | $95.0M | $8.8M | ||
| Q1 24 | $115.0M | $7.3M |
股东权益PGNYVMD
| Q4 25 | $516.0M | $141.5M | ||
| Q3 25 | $560.0M | $133.6M | ||
| Q2 25 | $515.0M | $139.7M | ||
| Q1 25 | $467.2M | $134.8M | ||
| Q4 24 | $422.1M | $131.4M | ||
| Q3 24 | $434.9M | $125.0M | ||
| Q2 24 | $456.2M | $119.4M | ||
| Q1 24 | $571.6M | $116.3M |
总资产PGNYVMD
| Q4 25 | $742.4M | $199.2M | ||
| Q3 25 | $795.2M | $202.4M | ||
| Q2 25 | $761.0M | $184.6M | ||
| Q1 25 | $730.3M | $178.1M | ||
| Q4 24 | $607.1M | $177.1M | ||
| Q3 24 | $660.0M | $169.5M | ||
| Q2 24 | $698.6M | $163.9M | ||
| Q1 24 | $794.3M | $154.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $18.4M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $9.7M |
| 自由现金流率自由现金流/营收 | 15.3% | 12.7% |
| 资本支出强度资本支出/营收 | 1.8% | 11.5% |
| 现金转化率经营现金流/净利润 | 4.34× | 3.27× |
| 过去12个月自由现金流最近4个季度 | $191.8M | $11.9M |
8季度趋势，按日历期对齐
经营现金流PGNYVMD
| Q4 25 | $54.2M | $18.4M | ||
| Q3 25 | $50.7M | $18.4M | ||
| Q2 25 | $55.5M | $12.3M | ||
| Q1 25 | $49.8M | $2.9M | ||
| Q4 24 | $52.2M | $15.0M | ||
| Q3 24 | $44.5M | $12.7M | ||
| Q2 24 | $56.7M | $10.2M | ||
| Q1 24 | $25.7M | $1.2M |
自由现金流PGNYVMD
| Q4 25 | $48.6M | $9.7M | ||
| Q3 25 | $46.0M | $10.7M | ||
| Q2 25 | $50.2M | $4.1M | ||
| Q1 25 | $47.0M | $-12.6M | ||
| Q4 24 | $50.3M | $3.2M | ||
| Q3 24 | $42.7M | $1.7M | ||
| Q2 24 | $55.8M | $1.2M | ||
| Q1 24 | $24.9M | $-4.8M |
自由现金流率PGNYVMD
| Q4 25 | 15.3% | 12.7% | ||
| Q3 25 | 14.7% | 14.9% | ||
| Q2 25 | 15.1% | 6.5% | ||
| Q1 25 | 14.5% | -21.4% | ||
| Q4 24 | 16.8% | 5.2% | ||
| Q3 24 | 14.9% | 3.0% | ||
| Q2 24 | 18.4% | 2.3% | ||
| Q1 24 | 8.9% | -9.5% |
资本支出强度PGNYVMD
| Q4 25 | 1.8% | 11.5% | ||
| Q3 25 | 1.5% | 10.6% | ||
| Q2 25 | 1.6% | 12.9% | ||
| Q1 25 | 0.9% | 26.2% | ||
| Q4 24 | 0.6% | 19.5% | ||
| Q3 24 | 0.6% | 19.0% | ||
| Q2 24 | 0.3% | 16.3% | ||
| Q1 24 | 0.3% | 11.9% |
现金转化率PGNYVMD
| Q4 25 | 4.34× | 3.27× | ||
| Q3 25 | 3.65× | 5.23× | ||
| Q2 25 | 3.24× | 3.88× | ||
| Q1 25 | 3.31× | 1.09× | ||
| Q4 24 | 4.95× | 3.47× | ||
| Q3 24 | 4.27× | 3.29× | ||
| Q2 24 | 3.44× | 6.94× | ||
| Q1 24 | 1.52× | 0.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
VMD
暂无分部数据
